|By PR Newswire||
|August 19, 2014 05:00 PM EDT||
TOWSON, Md., Aug. 19, 2014 /PRNewswire/ -- The Immune Deficiency Foundation (IDF) applauds a new study published August 19, 2014 in the Journal of the American Medical Association that underscores the importance of newborn screening for Severe Combined Immune Deficiency (SCID), also known as Bubble Boy disease.
Jennifer M. Puck, MD, senior author of the study and a renowned SCID expert, is also a member of IDF's Medical Advisory Committee. Said Puck, "The goal of all newborn screening tests is to identify infants with rare, but treatable conditions so that prompt, life-saving treatment can be given. SCID fits the criteria to be included in newborn screening panels, and now this large study shows the success of implementing SCID screening on a wide scale."
The retrospective study of more than 3 million infants in 10 states, plus the Navajo Area Indian Health Service, found an incidence of one case of SCID per 58,000 births, nearly twice the previously estimated rate of one in 100,000. The study also found that 92% of infants with SCID who received bone marrow transplants and other early interventions survived, underscoring the value of early detection and treatment. In addition to SCID, the screening test also identifies non-SCID conditions in which T lymphocytes may be dangerously low. Some of these were unrecognized prior to screening.
Marcia Boyle, president and founder of IDF said, "This study is one more key piece of evidence documenting the importance of SCID newborn screening, which allows SCID to be detected and treated before babies risk serious infection and death. Newborn screening not only saves lives but is also cost effective, saving an estimated $500,000 to 4 million per infant diagnosed."
IDF urges all states to adopt SCID newborn screening as part of their routine panels, as was recommended by the Department of Health and Human Services in 2010. When diagnosed and treated early, infants with SCID have over a 90% chance of being effectively "cured." This testing is now part of the standard newborn screening panel in 24 states.
The Immune Deficiency Foundation (IDF) is the national non-profit patient organization dedicated to improving the diagnosis, treatment and quality of life of persons with primary immunodeficiency diseases (PI) through advocacy, education and research. www.primaryimmune.org.
SOURCE Immune Deficiency Foundation
Dec. 6, 2016 12:30 PM EST Reads: 1,007
Dec. 6, 2016 12:30 PM EST Reads: 2,091
Dec. 6, 2016 12:28 PM EST Reads: 148
Dec. 6, 2016 11:54 AM EST Reads: 122
Dec. 6, 2016 11:30 AM EST Reads: 1,016
Dec. 6, 2016 11:15 AM EST Reads: 435
Dec. 6, 2016 11:00 AM EST Reads: 575
Dec. 6, 2016 10:30 AM EST Reads: 967
Dec. 6, 2016 10:30 AM EST Reads: 1,176
Dec. 6, 2016 10:15 AM EST Reads: 547
Dec. 6, 2016 09:00 AM EST Reads: 3,969
Dec. 6, 2016 09:00 AM EST Reads: 713
Dec. 6, 2016 09:00 AM EST Reads: 5,819
In his keynote at 18th Cloud Expo, Andrew Keys, Co-Founder of ConsenSys Enterprise, provided an overview of the evolution of the Internet and the Database and the future of their combination – the Blockchain. Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life sett...
Dec. 6, 2016 08:45 AM EST Reads: 7,130
Successful digital transformation requires new organizational competencies and capabilities. Research tells us that the biggest impediment to successful transformation is human; consequently, the biggest enabler is a properly skilled and empowered workforce. In the digital age, new individual and collective competencies are required. In his session at 19th Cloud Expo, Bob Newhouse, CEO and founder of Agilitiv, drew together recent research and lessons learned from emerging and established compa...
Dec. 6, 2016 08:30 AM EST Reads: 891